{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T03:12:22Z","timestamp":1787541142544,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ejmech.2023.115456","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T06:24:08Z","timestamp":1683786248000},"page":"115456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Discovery of highly potent and selective VEGFR2 kinase inhibitors for the treatment of rheumatoid arthritis"],"prefix":"10.1016","volume":"257","author":[{"given":"Qingling","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feilong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115456_bib1","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/annrheumdis-2019-215062","article-title":"Identification of rare coding variants in TYK2 protective for rheumatoid arthritis in the Japanese population and their effects on cytokine signalling","volume":"78","author":"Motegi","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejmech.2023.115456_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Res."},{"key":"10.1016\/j.ejmech.2023.115456_bib3","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2023.115456_bib4","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3390\/ijms19072012","article-title":"Implications of angiogenesis involvement in arthritis","volume":"19","author":"MacDonald","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115456_bib5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1080\/14397595.2016.1259717","article-title":"Differential effects of IL-6 blockade tocilizumab and TNF inhibitors on angiogenesis in synovial tissues from patients with rheumatoid arthritis","volume":"27","author":"Hirohata","year":"2017","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.ejmech.2023.115456_bib6","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1021\/acs.jafc.8b05047","article-title":"Resveratrol alleviates rheumatoid arthritis via reducing ROS and inflammation, inhibiting MAPK signaling pathways, and suppressing angiogenesis","volume":"66","author":"Yang","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2023.115456_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/cells8010032","article-title":"A disintegrin and metalloprotease 15 is expressed on rheumatoid arthritis synovial tissue endothelial cells and may mediate angiogenesis","volume":"8","author":"Nishimi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2023.115456_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174500","article-title":"Angiogenesis as a potential treatment strategy for rheumatoid arthritis","volume":"910","author":"Wang","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115456_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2018.07.009","article-title":"Succinate induces synovial angiogenesis in rheumatoid arthritis through metabolic remodeling and HIF-1\u03b1\/VEGF axis","volume":"126","author":"Li","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2023.115456_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1357-2725(99)00123-5","article-title":"Fibroblast growth factor-2","volume":"32","author":"Nugent","year":"2000","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.115456_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/74651","article-title":"Mechanisms of angiogenesis and arteriogenesis","volume":"6","author":"Carmeliet","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2023.115456_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-6147(00)01676-X","article-title":"FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition","volume":"22","author":"Cross","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2023.115456_bib13","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.1312256","article-title":"The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor","volume":"255","author":"de Vries","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115456_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/376062a0","article-title":"Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice","volume":"376","author":"Shalaby","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115456_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2023.115456_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1021\/acs.jmedchem.5b01582","article-title":"A novel potent oral series of VEGFR2 inhibitors abrogate tumor growth by inhibiting angiogenesis","volume":"59","author":"Bold","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115456_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jb\/mvs136","article-title":"Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases","volume":"153","author":"Shibuya","year":"2013","journal-title":"J. Biochem."},{"key":"10.1016\/j.ejmech.2023.115456_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10456-015-9477-2","article-title":"The pathogenic role of angiogenesis in rheumatoid arthritis","volume":"18","author":"Elshabrawy","year":"2015","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ejmech.2023.115456_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.816477","article-title":"\u03b2-Sitosterol inhibits rheumatoid synovial angiogenesis through suppressing VEGF signaling pathway","volume":"12","author":"Qian","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115456_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13075-021-02587-8","article-title":"Blocking Jak\/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis","volume":"23","author":"Benedetto","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejmech.2023.115456_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-642-01222-8_3","article-title":"Axitinib (AG-013736)","volume":"184","author":"Kelly","year":"2010","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115456_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.phrs.2017.03.010","article-title":"Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas","volume":"120","author":"Roskoski","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2023.115456_bib23","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1021\/jm501562a","article-title":"Nintedanib: from discovery to the clinic","volume":"58","author":"Roth","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115456_bib24","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/sj.bjc.6602603","article-title":"ZD6474--a novel inhibitor of VEGFR and EGFR tyrosine kinase activity","volume":"92","author":"Ryan","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2023.115456_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111609","article-title":"Pyrazolo-benzothiazole hybrids: synthesis, anticancer properties and evaluation of antiangiogenic activity using in vitro VEGFR-2 kinase and in vivo transgenic zebrafish model","volume":"182","author":"Reddy","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115456_bib26","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1016\/j.bmc.2019.07.007","article-title":"Design, synthesis, biological evaluation of benzoyl amide derivatives containing nitrogen heterocyclic ring as potential VEGFR-2 inhibitors","volume":"27","author":"Shen","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115456_bib27","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1080\/14756366.2019.1642883","article-title":"Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition","volume":"34","author":"Elmeligie","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115456_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126711","article-title":"Discovery of arylamide-5-anilinoquinazoline-8-nitro derivatives as VEGFR-2 kinase inhibitors: synthesis, in vitro biological evaluation and molecular docking","volume":"29","author":"Zhao","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115456_bib29","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.bmcl.2018.03.089","article-title":"Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors","volume":"28","author":"Ghorab","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115456_bib30","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1021\/acs.jmedchem.9b01336","article-title":"Bioisosteric discovery of NPA101.3, a second-generation RET\/VEGFR2 inhibitor optimized for single-agent polypharmacology","volume":"63","author":"Moccia","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115456_bib31","first-page":"3459","article-title":"Selective use of vandetanib in the treatment of thyroid cancer","volume":"9","author":"Fallahi","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2023.115456_bib32","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3390\/ijms19072012","article-title":"Implications of angiogenesis involvement in arthritis","volume":"19","author":"MacDonald","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115456_bib33","article-title":"Lenvatinib for hepatocellular carcinoma: from preclinical mechanisms to anti-cancer therapy","volume":"1874","author":"Zhao","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.ejmech.2023.115456_bib34","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.apsb.2019.10.004","article-title":"Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent","volume":"10","author":"Jiang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2023.115456_bib35","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1021\/jm061280h","article-title":"Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor","volume":"50","author":"Dai","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115456_bib36","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1002\/anie.201101379","article-title":"Cross-coupling reactions of organoboranes: an easy way to construct C-C bonds (Nobel Lecture)","volume":"50","author":"Suzuki","year":"2011","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2023.115456_bib37","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1021\/ol201564j","article-title":"Palladium-catalyzed cross-coupling of benzyl thioacetates and aryl halides","volume":"13","author":"Wager","year":"2011","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2023.115456_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.phrs.2015.10.021","article-title":"Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes","volume":"103","author":"Roskoski","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2023.115456_bib39","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1073\/pnas.0511292103","article-title":"An efficient rapid system for profiling the cellular activities of molecular libraries","volume":"103","author":"Melnick","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2023.115456_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108467","article-title":"AMSP-30 m as a novel HIF-1\u03b1 inhibitor attenuates the development and severity of adjuvant-induced arthritis in rats: impacts on synovial apoptosis, synovial angiogenesis and sonic hedgehog signaling pathway","volume":"103","author":"Meng","year":"2022","journal-title":"Int. Immunopharm."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423004221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423004221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T14:51:21Z","timestamp":1730991081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423004221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":40,"alternative-id":["S0223523423004221"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115456","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of highly potent and selective VEGFR2 kinase inhibitors for the treatment of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115456"}}